Suppr超能文献

Toll样受体4介导心脏缺血/再灌注损伤。

Toll-like receptor 4 mediates ischemia/reperfusion injury of the heart.

作者信息

Chong Albert J, Shimamoto Akira, Hampton Craig R, Takayama Hiroo, Spring Denise J, Rothnie Christine L, Yada Masaki, Pohlman Timothy H, Verrier Edward D

机构信息

Division of Cardiothoracic Surgery, Department of Surgery, The University of Washington, 1959 NE Pacific Street, Seattle, WA 98195, USA.

出版信息

J Thorac Cardiovasc Surg. 2004 Aug;128(2):170-9. doi: 10.1016/j.jtcvs.2003.11.036.

Abstract

BACKGROUND

Restoration of blood flow to the ischemic heart may paradoxically exacerbate tissue injury (ischemia/reperfusion injury). Toll-like receptor 4, expressed on several cell types, including cardiomyocytes, is a mediator of the host inflammatory response to infection. Because ischemia/reperfusion injury is characterized by an acute inflammatory reaction, we investigated toll-like receptor 4 activation in a murine model of regional myocardial ischemia/reperfusion injury. We used C3H/HeJ mice, which express a nonfunctional toll-like receptor 4, to assess the pertinence of this receptor to tissue injury after reperfusion of ischemic myocardium.

METHODS

Wild-type mice (C3H/HeN) or toll-like receptor 4 mutant mice (C3H/HeJ) were subjected to 60 minutes of regional myocardial ischemia followed by 2 hours of reperfusion. At the end of reperfusion, the area at risk and the myocardial infarct size were measured as the end point of myocardial ischemia/reperfusion injury. Myocardial mitogen-activated protein kinase activation was measured by Western blotting, and nuclear translocation of nuclear factor-kappaB and activator protein-1 was determined by electrophoretic mobility shift assay. Ischemia/reperfusion-injured myocardium was also assessed by ribonuclease protection assay for expression of inflammatory mediators (tumor necrosis factor-alpha, interleukin-1beta, monocyte chemotactic factor-1, and interleukin-6).

RESULTS

The area at risk was similar for all groups after myocardial ischemia/reperfusion injury. There was a 40% reduction in infarct size (as a percentage of the area at risk) in C3H/HeJ mice compared with C3H/HeN mice (P =.001). Within the myocardium, significant activation of c-Jun N-terminal kinase, p38, and extracellular signal-regulated kinase was observed in both strains after ischemia and during reperfusion as compared with an absence of mitogen-activated protein kinase activation during sham operations; however, c-Jun N-terminal kinase activity, but not p38 or extracellular signal-regulated kinase activity, was significantly reduced in C3H/HeJ mice (P <.05). In both groups, nuclear factor-kappaB and activator protein-1 nuclear translocation occurred in the myocardium during myocardial ischemia/reperfusion injury, but, by densitometric analysis, nuclear translocation of nuclear factor-kappaB and activator protein-1 was significantly decreased in C3H/HeJ mice compared with C3H/HeN mice. Interleukin-1beta, monocyte chemotactic factor-1, and interleukin-6 were detectable in reperfused ischemic myocardium but were not detected in sham-operated myocardium; the expression of each of these mediators was significantly decreased in the myocardial tissue of C3H/HeJ mice when compared with expression in the control C3H/HeN mouse strain.

CONCLUSIONS

Our data suggest that toll-like receptor 4 may mediate, at least in part, myocardial ischemia/reperfusion injury. Inhibition of toll-like receptor 4 activation may be a potential therapeutic target to attenuate ischemia/reperfusion-induced tissue damage in the clinical setting.

摘要

背景

恢复缺血心脏的血流可能会反常地加剧组织损伤(缺血/再灌注损伤)。Toll样受体4在包括心肌细胞在内的多种细胞类型上表达,是宿主对感染的炎症反应的介质。由于缺血/再灌注损伤的特征是急性炎症反应,我们在局部心肌缺血/再灌注损伤的小鼠模型中研究了Toll样受体4的激活情况。我们使用表达无功能Toll样受体4的C3H/HeJ小鼠,来评估该受体与缺血心肌再灌注后组织损伤的相关性。

方法

野生型小鼠(C3H/HeN)或Toll样受体4突变小鼠(C3H/HeJ)经历60分钟的局部心肌缺血,随后再灌注2小时。再灌注结束时,测量危险区域面积和心肌梗死大小,作为心肌缺血/再灌注损伤的终点。通过蛋白质印迹法测量心肌丝裂原活化蛋白激酶的激活情况,通过电泳迁移率变动分析确定核因子κB和活化蛋白-1的核转位。还通过核糖核酸酶保护试验评估缺血/再灌注损伤的心肌中炎症介质(肿瘤坏死因子-α、白细胞介素-1β、单核细胞趋化因子-1和白细胞介素-6)的表达。

结果

心肌缺血/再灌注损伤后,所有组的危险区域面积相似。与C3H/HeN小鼠相比,C3H/HeJ小鼠的梗死面积(占危险区域面积的百分比)减少了40%(P = 0.001)。在心肌内,与假手术期间丝裂原活化蛋白激酶未激活相比,缺血后和再灌注期间,两种品系的心肌中均观察到c-Jun氨基末端激酶、p38和细胞外信号调节激酶的显著激活;然而,C3H/HeJ小鼠的c-Jun氨基末端激酶活性显著降低(P < 0.05),但p38或细胞外信号调节激酶活性未降低。在两组中,心肌缺血/再灌注损伤期间心肌中均发生核因子κB和活化蛋白-1的核转位,但通过密度分析,与C3H/HeN小鼠相比,C3H/HeJ小鼠中核因子κB和活化蛋白-1的核转位显著减少。白细胞介素-1β、单核细胞趋化因子-1和白细胞介素-6在再灌注的缺血心肌中可检测到,但在假手术心肌中未检测到;与对照C3H/HeN小鼠品系中的表达相比,这些介质在C3H/HeJ小鼠的心肌组织中的表达均显著降低。

结论

我们的数据表明,Toll样受体4可能至少部分介导心肌缺血/再灌注损伤。抑制Toll样受体4的激活可能是在临床环境中减轻缺血/再灌注诱导的组织损伤的潜在治疗靶点。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验